May 29, 2024 · Transthyretin amyloid cardiomyopathy (ATTR-CM) is an underdiagnosed and potentially fatal disease of the heart muscle. As it progresses, the heart can become unable to …

A big problem in ATTR-CM is the buildup of amyloid proteins in the heart. New treatments aim to remove these proteins, which could help your heart work better and ease symptoms.

Jan 24, 2025 · Takeaways Transthyretin cardiac amyloidosis (ATTR-CM) is a potentially deadly form of heart disease. It causes your heart muscle to stiffen so that it becomes less able to …

Jun 26, 2025 · ATTR-CM (transthyretin amyloid cardiomyopathy) is a rare condition that causes a range of vague symptoms, including shortness of breath. If left untreated, it can progress to …

Transthyretin amyloidosis (ATTR-CM) is a buildup of faulty proteins (fibrils) on your heart or nerves. It can cause cardiomyopathy and heart failure.

Apr 8, 2025 · Transthyretin amyloid cardiomyopathy (ATTR-CM) is a type of heart disease that happens when an abnormal protein called amyloid builds up in the heart. Because the …

Jul 29, 2019 · Transthyretin amyloid cardiomyopathy (ATTR-CM) is a serious disease that affects the left ventricle of the heart. Learn about symptoms and treatment.

Mar 3, 2025 · The Good Brigade/Getty Images Transthyretin amyloid cardiomyopathy, or ATTR-CM, is an underdiagnosed heart condition with symptoms that mimic other conditions. Here’s …

Explore the red flags of transthyretin-mediated amyloidosis with cardiomyopathy (ATTR-CM), the signs and symptoms that should prompt additional assessments.

Delayed diagnosis of ATTR-CM prevents timely intervention and contributes to premature death. Learn about diagnosis, symptoms, subtypes and more.